• Feb 10, 2025

Incyte (NASDAQ:INCY) Posts Better-Than-Expected Sales In Q4

Biopharmaceutical company Incyte Corporation (NASDAQ:INCY) announced better-than-expected revenue in Q4 CY2024, with sales up 16.3% year on year to $1.18 billion. Its non-GAAP profit of $1.43 per share was 8% below analysts’ consensus estimates.

  • Feb 10, 2025

German economy minister says Europe prepared to act on possible trade restrictions

Europe is prepared to act in response to possible restrictions to trade, German Economy Minister Robert Habeck said on Monday, after holding discussions with industry lobbies and the EU's top trade representative about the threat of tariffs from the U.S. Habeck held a roundtable with industry on future trans-Atlantic relations on Monday and spoke with EU trade commissioner Maros Sefcovic on the phone, according to the statement.

  • Feb 10, 2025

Monday.com’s (NASDAQ:MNDY) Q4 Sales Top Estimates, Stock Jumps 19.6%

Project management software maker Monday.com (NASDAQ:MNDY) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 32.3% year on year to $268 million. The company expects next quarter’s revenue to be around $275 million, close to analysts’ estimates. Its non-GAAP profit of $1.08 per share was 36.8% above analysts’ consensus estimates.

  • Feb 10, 2025

McDonald's international markets prop up sales growth even as US lags

(Reuters) -McDonald's global comparable sales posted a surprise rise in the fourth quarter on Monday, aided by demand for its affordable burgers and fries among diners in the Middle East, Japan and China. Shares of the burger chain rose nearly 5% in early trading, despite a bigger-than-expected drop in the U.S. comparable sales due to an E.coli outbreak in late October and cautious spending. Demand pressure on fast-food chains operating in the Middle East has slowly begun to ease after widespread informal boycotts of Western fast-food chains over their perceived pro-Israeli stance in the Gaza conflict.